Lec 15- STEMI NSTEMI Flashcards

1
Q

MI (STEMI)

A

3 diagnosis factors- all can be ambiguous
Symptoms
-Prologonged severe chest pain (gripping or crushing, may radiate down arm, across back or up through jaw)
-Sensations of suffocating/doom
-Nausea
-Dizziness
-Sweating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Myocardial infarction

A

3 diagnosis factors- all can be ambiguous

signs: Dysrhythmias are common; ECG changes-12 lead ECG needed to look for global changes; Increased cardiac component in the blood- troponin T
- Silent AMI
- Estimated that 25% of non-fatal MI’s are not recognised
- Often serious MI will show signs of previous silent episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ECG abnormalities

LOOK on BB at the abnormalities

A
  • T wave inversion or elevation: denotes ischemia
  • ST-segment elevation: denotes myocardial injury; may be seen as depression in leads viewing electrical potential moving away
  • Q wave abnormalities: deep often broad wave usually >25% of following R wave. Denotes infraction
  • Non-ST segment elevation ACS: Is less serious. There, maybe no other ECG changes and diagnosis by symptoms and cardiac cell markers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ST segment ECG

A
ST-segment elevation (STEMI) 
-Increased R wave amplitude 
-ST elevation which is sloped upward 
Prominent Q wave 
-Prominent Q wave deeper and broader 
-Elevated ST segments 
-Inverted 'arrowhead' T waves
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Q wave

A
  • Many people who have had prior MI will have an ECG that appears normal
  • There may, however, be typical features of previous MI, and the most conspicuous of these is abnormal Q waves
  • Often accompanied by reducing R wave
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Plasma cardiac components

A
  • Only used cardiac marker is Troponin T- isoenzyme more specific for heart
  • Mainly used to distinguish NSTEMI once no ECG changes found
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

2012 data on MI

A
  • 79,000 hospital admission
  • 41% STEMI and 59% NSTEMI
  • Twice number of males cf.females
  • 30 day mortality 2011-12 8% cf 13% in 2003/4
  • 2013 >1 million men and 500k women in the UK who have had an MI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MI: the early stages

A
  • 23% sudden death before hospitalisation
  • Another 13% die during admission
  • Irreversible damage to the cardiac muscle occurs within 6 hours- but still, some benefit up to 12 hours
  • SPEED is vital
  • Defibrillators are now common with some airlines and in shopping malls
  • Aspirin 300mg should be given if not contra-indicated (chewed)- ASAP
  • FAST TRACT FOR PCI
  • Even with treatment, 5% die in the 1st year and then about 5% per year indefinitely. prognosis linked to the degree of necrosis- measured by troponin, T elevation and ECG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Immediate complications 1

A

-Acute left ventricular failure and pulmonary oedema
Lung signs- chest x-ray; increased pulmonary wedge pressure; lung base crack
-All patients to have a bedside echocardiogram to determine EF
May be transient. May then respond to O2 therapy (not COPD; alternatively furosemide oral or IV
Severe is difficult to treat (cardiogenic shock). If CO good then vasodilators to reduce TPR. Need haemodynamic control- monitoring right atrial, pulmonary wedge CO
-Cardiac Arrhythmias: common extra ventricular beats, ventricular tachycardia; ventricular fibrillation. May also see atrial fibrillation; sinus tachycardia and heart block. All patients to have continuous ECG monitoring 48 hrs
Treatment- depends on the type of arrhythmia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Complication 2

A
  • Cardiogenic shock: hypotension, SBP <90, cold, clammy, cyanosed, hyperventilation, high shallow pulse, oliguria
  • 90% mortality even with therapy
  • Haemodynamic monitoring
  • Dobutamine/Dopamine- positive inotropes minimum effect on rate. Dopamine increases renal blood flow (dopamine R)
  • Positive ventilation
  • Avoid cardiac glycosides- may increase risk of arrhythmia; increase myocardial O2 consumption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Infarction

A
  • Means stuffing because of (later) collagen scars
  • Irreversible damage to heart muscle
  • Necrosis occurs first, then infarction
  • Transmural or subendocardial (most common)
  • The initial injury may spread into adjacent areas. An important therapeutic objective is to limit the infarct size
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cellular events following occlusion

A
  • In affected area, aerobic metabolism –> anaerobic
  • ATP levels fall, lactic acid accumulates. Fall in pH; fall in compliance
  • Inhibition of Na/K pump (depolarization). Intracellular accumulation of Na and Ca; swelling
  • Extracellular accumulation of K, causing electrical instability
  • Ca accumulation activates lipases and proteases destroying cell and damaging adjacent tissue
  • Necrosis causes a weakening and a thinning of heart wall with a risk of aneurysm rupture
  • Necrotic area is invaded by macrophages and replaced by collagen at about 7 days; healing completed at about 7 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Therapeutic strategies

A

-Non-ST elevation MI is treated like unstable angina
Much less myocardial necrosis
-ST elevation MI- marked myocardial necrosis
-Broad similarities for both- with treatment depending on symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MI: immediate management

A
  • If no pulse: external cardiac massage; electro version (defibrillation)
  • Pulse present- severe pain: morphine and anti-emetic
  • O2 (40%); if evidence of hypoxia or continued myocardial ischemia (More risk with COPD)
  • Bed rest (sedation if required); ECG monitoring
  • Antiarrhythmics if necessary
  • If signs of failure or shock: vasodilators/diuretic; inotropic
  • URGENT PCI LISTING
  • Stat loading doses of aspirin and another antiplatelet e.g. prasugrel and clopidogrel
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Percutaneous Coronary Intervention PCI- Give loading dose of DAPT before

A
  • insert a stent after balloon angioplasty
  • If at point of angiogram no blockage is found- it is not an MI, likely broken heart syndrome for review by team
  • If at point of angiogram blockages are not settable- ti be reviewed for possible coronary artery bypass grafting
  • Negatives: Metal stent could damage area causing immune response; metal can catch fatty deposits causing blockage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Post PCI treatment

A
  • If the PCI was successful we have fixed the blockage. Treatment therefore afterwards is to: reduce further heart attacks; maintain heart function and reduce progression to heart failure
  • Dual antiplatelet therapy (DAPT)
  • Atorvastatin 80mg OD
  • ACEI
  • BB
  • VTE prophylaxis for hospital stay
  • GTN spray- microvascular could be affected and angina attacks could occur
17
Q

Dual antiplatelet therapy

aspirin

A

Aspirin plus one of clopidogrel; prasugrel; ticagrelor

  • 12-month min (then aspirin lifelong)
  • Trials ongoing for extended use of DAPT
  • High-risk patient will have extended therapy
  • Durations altered if patient has to take an anti-coagulant as well
18
Q

DAPT: rationale; stents; monitoring

A

Rationale- potential platelet aggregation on stent
Stent (choice made by consultant)
-bare metal: shorter risk period -Drug eluting: longer revascular time, longer risk period
Monitoring; signs of bleeding; platelets; Hb

19
Q

Choice of 2nd DAPT agent

A

Clopidogrel (original agent- still used if doesn’t fit criteria for other agents)
Prasugrel
- faster time to max effect than clopidogrel- no metabolic step
-1st line unless previous history of CVA/TIA; is >75 or <60kg lower doses but may prefer clopidogrel
Ticagrelor- slightly different mode of action; more potent
-Higher risk of bleeding; both STEMI and 2nd line ACS protocols, mainly for patient who have already occluded with other agents or whilst on the table

20
Q

ACEI

A
  • ACEI improve outcome (with or without signs of HF)
  • Offer ACEI as soon as haemodynamically stable.
  • Titrate dose upwards over short period of time to max tolerated dose
  • Continue ACEI indefinatly. clinical evidence relatively weak on duration
  • Use ACEI in both NSTEMI and STEMI also now use for patients with proven MI more than 12 months ago
  • Use ARB if ACEI not tolerated
  • Monitor: renal function and K+
21
Q

BB

A
  • Offer as soon as possible after MI when the person is haemodynamically stable
  • Escalate up to highest tolerable dose
  • Continue for at least 12 months if no LV dysfunction or HR
  • Continue indefinitely if LVD or HF
  • Offer to all with MI more than 12 months ago with lVD or HF
  • Choice of BB should be cardiac selective: bisoprolol; carvediolol
  • Monitor: pulse and BP
22
Q

Statins

A
  • cG67 recommends statins in treatment plan for all CV disease
  • Atorvastatin 80mg OD except: High risk of adverse effects; potential drug interactions; patient preference
  • NICE recommend- aim for a greater than 40% reduction in non-HDL CHE at 3/12
  • Monitoring: LFT after 3/12 and 12/12, questions about muscle myopathy
23
Q

NSTEMI and unstable angina

A
  • initial loading dose immediate of aspirin 300mg. Then 75mg given daily indefinitely
  • Acutely pain relief as per STEMI
  • In NSTEMI unless lowest risk <1.5% clopidogrel with aspirin for up to 12 months, most benefit in 1st 3 months
  • If risk >3% offer coronary angiogram and follow-on PCI within 96 hours of admission
  • CABG may be the last resort depending on risk and co-morbidities- the angiogram will assess if arteries un-stable and if this is required
24
Q

Post STEMI (cardiac failure)

A
  • As previously plus
  • Eplerenone
  • Loop diuretics- may be needed long term to reduce volume load
  • If symptomatic of HF other treatments may be added see HF lecture
  • Determined initially by bedside echocardiogram to check EF- depending on din fins may be sent for further assessment and myocardial perfusion scanning
25
Q

MI in diabetic patients

A

INTENSIVE INSLUIN THERAPY

  • initially given as sliding scale pump of insulin
  • QDS insulin doses continuing for at least 3 months (basal bolus therapy)
  • Diabetic normally have poor prognosis in MI- linked to poor ability to withstand stress
  • Insulin therapy can half the mortality in the near MI phase- even in diabetics not normally controlled by insulin
  • Attention to controlling all CVS disorders and glycemic control
26
Q

Holistic approach

A
  • Cardiac rehabilitation programme with exercise
  • No smoking
  • Manage psychological problems- depression cognitive behavioural therapy
  • Healthy diet not just low fat diet: replace saturated and trans fats; increase omega-3; high fruit and veg; FISH: